Reply to the letter to the editor 'duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients' by Fouad et al.
Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria michael.gnant@meduniwien.ac.at.
M
M
Gnant
Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
P C
PC
Dubsky
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans
D050071:Bone Density Conservation Agents